| Literature DB >> 175019 |
Abstract
Treatment of bacterial lipopolysaccharides (endotoxins) isolated from Salmonella minnesota R595 or purified lipid A with the antibiotic polymyxin B has been demonstrated to abrogate the ability of these molecules to activate serum complement. The inhibition is a function of the ratio of polymyxin B to lipopolysaccharide.Entities:
Mesh:
Substances:
Year: 1976 PMID: 175019 PMCID: PMC420610 DOI: 10.1128/iai.13.1.298-301.1976
Source DB: PubMed Journal: Infect Immun ISSN: 0019-9567 Impact factor: 3.441